Your browser doesn't support javascript.
loading
Basiliximab lowers the cyclosporine therapeutic threshold in the early post-kidney transplant period.
Balbontin, F; Kiberd, B; Fraser, A; Kiberd, M; Lawen, J.
Affiliation
  • Balbontin F; Department of Urology, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada.
Clin Transplant ; 19(2): 225-9, 2005 Apr.
Article in En | MEDLINE | ID: mdl-15740559
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Kidney Transplantation / Cyclosporine / Immunosuppressive Agents / Antibodies, Monoclonal / Mycophenolic Acid Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Clin Transplant Journal subject: TRANSPLANTE Year: 2005 Document type: Article Affiliation country: Canadá Country of publication: Dinamarca
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Recombinant Fusion Proteins / Kidney Transplantation / Cyclosporine / Immunosuppressive Agents / Antibodies, Monoclonal / Mycophenolic Acid Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Clin Transplant Journal subject: TRANSPLANTE Year: 2005 Document type: Article Affiliation country: Canadá Country of publication: Dinamarca